These lab-made solutions were not developed with recreational use in mind. While in the nineties, John W. Huffman and a team of fellow chemists at Clemson University made a number of the 1st formulation for artificial cannabinoid receptor agonists (SCRAs), a spouse and children of substances that imitate the physiological and psychological impacts